MIAMI BEACH, Fla. — The pharmaceutical industry has long dominated television advertising with blockbuster drugs and massive budgets. But connected TV is rewriting those rules, potentially giving smaller, precision medicine brands access to premium inventory they could never previously afford. It’s a change in how healthcare marketers can reach specific patient populations during high-impact viewing moments. A niche oncology drug, for instance, …
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.